Observational studyAesthetic plastic surgery2026
Clinical Outcomes in Women with Breast Implant Illness After Removal Surgery: Experience from a Latin American Center.
Observational study in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the impact of removal surgery in women with breast implant illness (BII) on the improvement of symptoms, as well as on the current quality of life of women.
methodsThis is an observational study of a cohort of women undergoing definitive implant removal for BII-related symptomatology between 2016 and 2022 in Cali, Colombia. All data were collected from medical records and through a telephone survey. The severity of 10 clinical manifestations before and after removal surgery was evaluated with a five-point Likert scale. Quality of life was assessed with the BREAST-Q scale.
resultsA total of 125 women who underwent breast removal surgery were included; mean age was 48.8 ±9.7 years. The three most frequent reported symptoms at baseline were sore/aching joint (48.0%), fatigue (32.0%), and hair loss (25.6%). At a median follow-up of 18 months after implant removal, significant improvement was observed in all symptoms (p value<0.05) with a mean reduction in the percentage of women with symptomatology of 55.8% ±6.4%. At least half of the women reported a BREAST-Q of 100 points on the dimensions of satisfaction with breasts, physical well-being, and satisfaction with surgical outcome.
conclusionThis study provides evidence in favor of breast removal surgery as a treatment option in women with BII symptomatology. Highlights Nowadays, the evidence on breast implant illness is not conclusive. However, due to media interest and growing concern among patients and decision-makers, it is necessary to increase knowledge about BII, especially in low- and middle-income countries where evidence is poor. Consistent with the results of other studies, implant removal surgery significantly reduced the severity of symptoms at a median follow-up of 18 months after explantation in 125 women included in this study. Women after explantation reported a good quality of life and satisfaction with their breast appearance, physical well-being and surgical outcome with the BREAST-Q score. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41136705What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.